Bérengère Fayard

Title: Bérengère Fayard: Innovator in Cancer Research

Introduction

Bérengère Fayard is a notable inventor based in Sierentz, France. He has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. His innovative work focuses on the mechanisms of metastasis and how they can be inhibited.

Latest Patents

Fayard holds a patent for the "Use of protease nexin 1 inhibitors to reduce metastasis." This invention relates to a method of inhibiting metastasis through the administration of an inhibitor of protease nexin-1 (PN-1). The method is characterized by the administration of the inhibitor at a therapeutic dosage that does not completely inhibit the expression and/or activity of PN-1. This approach aims to provide a more effective treatment option for patients suffering from cancer.

Career Highlights

Bérengère Fayard is associated with the Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research. His work at this prestigious institution has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Fayard has worked alongside Denis Monard, enhancing the research efforts in their shared field of study. Their collaboration has been instrumental in advancing the understanding of cancer metastasis and potential therapeutic interventions.

Conclusion

Bérengère Fayard's innovative contributions to cancer research, particularly through his patent on protease nexin-1 inhibitors, highlight his commitment to improving treatment options for patients. His work continues to inspire advancements in biomedical research.